Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia.

Ajay Jawahar, Rishi Wadhwa, Caglar Berk, Gloria Caldito, Allyson DeLaune, Federico Ampil, Brian Willis, Donald Smith, Anil Nanda

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

OBJECT: There are various surgical treatment alternatives for trigeminal neuralgia (TN), but there is no single scale that can be used uniformly to assess and compare one type of intervention with the others. In this study the objectives were to determine factors associated with pain control, pain-free survival, residual pain, and recurrence after gamma knife surgery (GKS) treatment for TN, and to correlate the patients' self-reported quality of life (QOL) and satisfaction with the aforementioned factors. METHODS: Between the years 2000 and 2004, the authors treated 81 patients with medically refractory TN by using GKS. Fifty-two patients responded to a questionnaire regarding pain control, activities of daily living, QOL, and patient satisfaction. The median follow-up duration was 16.5 months. Twenty-two patients (42.3%) had complete pain relief, 14 (26.9%) had partial but satisfactory pain relief, and in 16 patients (30.8%) the treatment failed. Seven patients (13.5%) reported a recurrence during the follow-up period, and 25 (48.1%) reported a significant (> 50%) decrease in their pain within the 1st month posttreatment. The mean decrease in the total dose of pain medication was 75%. Patients' self-reported QOL scores improved 90% and the overall patient satisfaction score was 80%. CONCLUSIONS: The authors found that GKS is a minimally invasive and effective procedure that yields a favorable outcome for patients with recurrent or refractory TN. It may also be offered as a first-line surgical modality for any patients with TN who are unsuited or unwilling to undergo microvascular decompression.

Original languageEnglish (US)
JournalNeurosurgical focus
Volume18
Issue number5
StatePublished - Jan 1 2005
Externally publishedYes

Fingerprint

Trigeminal Neuralgia
Pain Measurement
Quality of Life
Pain
Therapeutics
Patient Satisfaction
Microvascular Decompression Surgery
Recurrence
Activities of Daily Living
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Clinical Neurology

Cite this

Jawahar, Ajay ; Wadhwa, Rishi ; Berk, Caglar ; Caldito, Gloria ; DeLaune, Allyson ; Ampil, Federico ; Willis, Brian ; Smith, Donald ; Nanda, Anil. / Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia. In: Neurosurgical focus. 2005 ; Vol. 18, No. 5.
@article{cb6461e331f34fbd9be93305fe5eec1d,
title = "Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia.",
abstract = "OBJECT: There are various surgical treatment alternatives for trigeminal neuralgia (TN), but there is no single scale that can be used uniformly to assess and compare one type of intervention with the others. In this study the objectives were to determine factors associated with pain control, pain-free survival, residual pain, and recurrence after gamma knife surgery (GKS) treatment for TN, and to correlate the patients' self-reported quality of life (QOL) and satisfaction with the aforementioned factors. METHODS: Between the years 2000 and 2004, the authors treated 81 patients with medically refractory TN by using GKS. Fifty-two patients responded to a questionnaire regarding pain control, activities of daily living, QOL, and patient satisfaction. The median follow-up duration was 16.5 months. Twenty-two patients (42.3{\%}) had complete pain relief, 14 (26.9{\%}) had partial but satisfactory pain relief, and in 16 patients (30.8{\%}) the treatment failed. Seven patients (13.5{\%}) reported a recurrence during the follow-up period, and 25 (48.1{\%}) reported a significant (> 50{\%}) decrease in their pain within the 1st month posttreatment. The mean decrease in the total dose of pain medication was 75{\%}. Patients' self-reported QOL scores improved 90{\%} and the overall patient satisfaction score was 80{\%}. CONCLUSIONS: The authors found that GKS is a minimally invasive and effective procedure that yields a favorable outcome for patients with recurrent or refractory TN. It may also be offered as a first-line surgical modality for any patients with TN who are unsuited or unwilling to undergo microvascular decompression.",
author = "Ajay Jawahar and Rishi Wadhwa and Caglar Berk and Gloria Caldito and Allyson DeLaune and Federico Ampil and Brian Willis and Donald Smith and Anil Nanda",
year = "2005",
month = "1",
day = "1",
language = "English (US)",
volume = "18",
journal = "Neurosurgical Focus",
issn = "1092-0684",
publisher = "American Association of Neurological Surgeons",
number = "5",

}

Jawahar, A, Wadhwa, R, Berk, C, Caldito, G, DeLaune, A, Ampil, F, Willis, B, Smith, D & Nanda, A 2005, 'Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia.', Neurosurgical focus, vol. 18, no. 5.

Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia. / Jawahar, Ajay; Wadhwa, Rishi; Berk, Caglar; Caldito, Gloria; DeLaune, Allyson; Ampil, Federico; Willis, Brian; Smith, Donald; Nanda, Anil.

In: Neurosurgical focus, Vol. 18, No. 5, 01.01.2005.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Assessment of pain control, quality of life, and predictors of success after gamma knife surgery for the treatment of trigeminal neuralgia.

AU - Jawahar, Ajay

AU - Wadhwa, Rishi

AU - Berk, Caglar

AU - Caldito, Gloria

AU - DeLaune, Allyson

AU - Ampil, Federico

AU - Willis, Brian

AU - Smith, Donald

AU - Nanda, Anil

PY - 2005/1/1

Y1 - 2005/1/1

N2 - OBJECT: There are various surgical treatment alternatives for trigeminal neuralgia (TN), but there is no single scale that can be used uniformly to assess and compare one type of intervention with the others. In this study the objectives were to determine factors associated with pain control, pain-free survival, residual pain, and recurrence after gamma knife surgery (GKS) treatment for TN, and to correlate the patients' self-reported quality of life (QOL) and satisfaction with the aforementioned factors. METHODS: Between the years 2000 and 2004, the authors treated 81 patients with medically refractory TN by using GKS. Fifty-two patients responded to a questionnaire regarding pain control, activities of daily living, QOL, and patient satisfaction. The median follow-up duration was 16.5 months. Twenty-two patients (42.3%) had complete pain relief, 14 (26.9%) had partial but satisfactory pain relief, and in 16 patients (30.8%) the treatment failed. Seven patients (13.5%) reported a recurrence during the follow-up period, and 25 (48.1%) reported a significant (> 50%) decrease in their pain within the 1st month posttreatment. The mean decrease in the total dose of pain medication was 75%. Patients' self-reported QOL scores improved 90% and the overall patient satisfaction score was 80%. CONCLUSIONS: The authors found that GKS is a minimally invasive and effective procedure that yields a favorable outcome for patients with recurrent or refractory TN. It may also be offered as a first-line surgical modality for any patients with TN who are unsuited or unwilling to undergo microvascular decompression.

AB - OBJECT: There are various surgical treatment alternatives for trigeminal neuralgia (TN), but there is no single scale that can be used uniformly to assess and compare one type of intervention with the others. In this study the objectives were to determine factors associated with pain control, pain-free survival, residual pain, and recurrence after gamma knife surgery (GKS) treatment for TN, and to correlate the patients' self-reported quality of life (QOL) and satisfaction with the aforementioned factors. METHODS: Between the years 2000 and 2004, the authors treated 81 patients with medically refractory TN by using GKS. Fifty-two patients responded to a questionnaire regarding pain control, activities of daily living, QOL, and patient satisfaction. The median follow-up duration was 16.5 months. Twenty-two patients (42.3%) had complete pain relief, 14 (26.9%) had partial but satisfactory pain relief, and in 16 patients (30.8%) the treatment failed. Seven patients (13.5%) reported a recurrence during the follow-up period, and 25 (48.1%) reported a significant (> 50%) decrease in their pain within the 1st month posttreatment. The mean decrease in the total dose of pain medication was 75%. Patients' self-reported QOL scores improved 90% and the overall patient satisfaction score was 80%. CONCLUSIONS: The authors found that GKS is a minimally invasive and effective procedure that yields a favorable outcome for patients with recurrent or refractory TN. It may also be offered as a first-line surgical modality for any patients with TN who are unsuited or unwilling to undergo microvascular decompression.

UR - http://www.scopus.com/inward/record.url?scp=33646981975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646981975&partnerID=8YFLogxK

M3 - Article

C2 - 15913284

AN - SCOPUS:33646981975

VL - 18

JO - Neurosurgical Focus

JF - Neurosurgical Focus

SN - 1092-0684

IS - 5

ER -